98%
921
2 minutes
20
Background: Capturing sleep data historically required complex, expensive, and labour-intensive equipment, with the gold standard being overnight polysomnography (PSG). Newer portable devices, such as the Dreem 3 headband, provide a novel opportunity to collect field-based data and have demonstrated accuracy in healthy sleepers compared to PSG. However, this device's performance has not been assessed in Insomnia Disorder, despite sleep-tracking technologies traditionally performing poorly in disordered sleepers. This study aimed to evaluate the performance of Dreem 3 against PSG on key sleep outcomes.
Methods: Thirty-one adults (M = 45.9 years, 16 males) with Insomnia Disorder participated in an overnight sleep study wearing Dreem 3 and PSG simultaneously. Sensitivity and specificity were calculated using an epoch-by-epoch analysis. Bland-Altman plots further assessed performance related to sleep stages and continuity variables: total sleep time (TST), sleep efficiency (SE), sleep latency (SL), and wake after sleep onset (WASO).
Results: Dreem 3 showed the highest sensitivity for REM sleep (89.88 %) and the lowest sensitivity for N1 (29.79 %). N3 sensitivity was also notably low (65.65 %). Specificity was >90 % for all stages, except N2 (83.39 %). Dreem accurately summarised SL and WASO but significantly overestimated TST and SE.
Conclusion: The Dreem 3 headband can accurately evaluate and report most sleep staging and continuity variables in individuals with Insomnia Disorder. Users should be mindful of the strengths and limitations of the device when deciding whether the Dreem 3 is suitable for their needs. If applied and interpreted correctly, this device could facilitate large-scale, longitudinal sleep studies and assessment of sleep in Insomnia Disorder.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.sleep.2025.106698 | DOI Listing |
J Med Internet Res
September 2025
Department of Psychiatry, Helsinki University Hospital and Helsinki University, Helsinki, Finland.
Background: Internet-based cognitive behavioral therapies (iCBTs) are typically categorized into 2 types: therapist-assisted and self-guided. Both formats have accumulated substantial evidence supporting their cost-effectiveness and efficacy in treating a range of mental health conditions. However, therapist-assisted iCBTs tend to show lower dropout rates than self-guided versions.
View Article and Find Full Text PDFNeurology
October 2025
Department of Radiology, Mayo Clinic, Rochester, MN.
Background And Objectives: The relationship between insomnia and cognitive decline is poorly understood. We investigated associations between chronic insomnia, longitudinal cognitive outcomes, and brain health in older adults.
Methods: From the population-based Mayo Clinic Study of Aging, we identified cognitively unimpaired older adults with or without a diagnosis of chronic insomnia who underwent annual neuropsychological assessments (z-scored global cognitive scores and cognitive status) and had quantified serial imaging outcomes (amyloid-PET burden [centiloid] and white matter hyperintensities from MRI [WMH, % of intracranial volume]).
Braz Oral Res
September 2025
Universidade de Ribeirão Preto - Unaerp, Graduate Program in Dentistry, Ribeirão Preto, SP, Brazil.
The aim of this study was to assess the prevalence of temporomandibular disorder (TMD) and associated factors in an adult population in southern Brazil. The population-based sample (n = 4.65) included participants from Passo Fundo, a town in southern Brazil.
View Article and Find Full Text PDFInt J Soc Psychiatry
September 2025
Department of Community Medicine, All India Institute of Medical Sciences, Nagpur, MH, India.
Introduction: Night Eating Syndrome (NES) is a distinct psychopathological entity variously considered as a mental health disorder, eating disorder or circadian rhythm disorder. Medical students are faced with hectic schedules, sleep interruptions and high-stakes exams as they become healthcare providers. Such social factors coupled with poor dietary practices may impact their mental health and biological clocks, leading to NES amongst this population.
View Article and Find Full Text PDFBasic Clin Pharmacol Toxicol
October 2025
HUS Pharmacy, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
While deprescribing benzodiazepines and related drugs (BZRDs) is crucial for preventing prolonged use and their associated adverse effects, it presents challenges from a healthcare perspective, because of limited resources and time. Recently, a pharmacist-led deprescribing of BZRDs in the treatment of insomnia was introduced in Helsinki's primary care health centres. To explore pharmacists' and physicians' insights, qualitative semi-structured interviews were conducted via Microsoft Teams with physicians and pharmacists involved in a pharmacist-led deprescribing.
View Article and Find Full Text PDF